Jaguar Health appoints Dr. Anula Jayasuriya to board, forms Business Development Advisory Committee

Jaguar Health, Inc.

Greg Divis resigned from Jaguar Health board effective July 1, 2022, after serving since 2018.
Dr. Anula Jayasuriya appointed as Class III director effective July 1, 2022; founder of EXXclaim Capital.
Board formed Business Development Advisory Committee chaired by Rachel Zolot Schwartz, VP at Volastra Therapeutics.
Dr. Jayasuriya receives $40,000 cash retainer and 128,851 restricted stock units under the 2014 Stock Incentive Plan.
Committee to identify and assess opportunities for potential alliances, mergers, and acquisitions for crofelemer asset.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Greg J. Divis

Member of the Board

JAGX · Jaguar Health, Inc.

Effective: 2022-07-01
Successor: Dr. Anula Jayasuriya
Filed: July 6, 2022, 7:59 PM ET

Mr. Greg J. Divis notified the Board of Directors (the “Board”) of Jaguar Health, Inc. (the “Company”) of his intention to resign as a member of the Board, effective as of July 1, 2022.

Appointed

Anula Jayasuriya

Class III Director

JAGX · Jaguar Health, Inc.

Effective: 2022-07-01
Filed: July 6, 2022, 7:59 PM ET

the Board, by resolution as contemplated in the Company’s bylaws, appointed Dr. Anula Jayasuriya to fill the vacancy created by Mr. Divis’s resignation and serve as Class III director of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Greg J. Divis resigned as Member of the Board at Jaguar Health, Inc..

Action: resigned
Role: Member of the Board

Exact text from the filing

Mr. Greg J. Divis notified the Board of Directors (the “Board”) of Jaguar Health, Inc. (the “Company”) of his intention to resign as a member of the Board, effective as of July 1, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Anula Jayasuriya was appointed as Class III Director at Jaguar Health, Inc..

Action: appointed
Role: Class III Director

Exact text from the filing

the Board, by resolution as contemplated in the Company’s bylaws, appointed Dr. Anula Jayasuriya to fill the vacancy created by Mr. Divis’s resignation and serve as Class III director of the Company

View on SEC.gov

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-077715

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.